Nuvalent (NASDAQ:NUVL) Coverage Initiated by Analysts at Jefferies Financial Group
Jefferies Financial Group started coverage on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a research report report published on Wednesday, MarketBeat Ratings reports. The firm issued a buy rating and a $97.00 price objective on the stock. NUVL has been the topic of several other research reports. Leerink Partnrs raised shares of Nuvalent from […]
More Stories
Price T Rowe Associates Inc. MD Purchases 4,367 Shares of WaFd, Inc (NASDAQ:WAFD)
Price T Rowe Associates Inc. MD boosted its holdings in WaFd, Inc (NASDAQ:WAFD – Free Report) by 10.6% during the...
Price T Rowe Associates Inc. MD Acquires 9,426 Shares of MasterBrand, Inc. (NYSE:MBC)
Price T Rowe Associates Inc. MD lifted its holdings in shares of MasterBrand, Inc. (NYSE:MBC – Free Report) by 10.6%...
Price T Rowe Associates Inc. MD Purchases 8,324 Shares of Vishay Intertechnology, Inc. (NYSE:VSH)
Price T Rowe Associates Inc. MD raised its position in shares of Vishay Intertechnology, Inc. (NYSE:VSH – Free Report) by...
Price T Rowe Associates Inc. MD Raises Stock Holdings in Northwest Natural Holding (NYSE:NWN)
Price T Rowe Associates Inc. MD increased its stake in shares of Northwest Natural Holding (NYSE:NWN – Free Report) by...
Price T Rowe Associates Inc. MD Raises Stake in Ingevity Co. (NYSE:NGVT)
Price T Rowe Associates Inc. MD grew its position in Ingevity Co. (NYSE:NGVT – Free Report) by 7.8% in the...
Insider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Director Sells 30,000 Shares of Stock
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) Director William H. Rastetter sold 30,000 shares of the firm’s stock in...